The Alliance for Aging Research interviewed experts from around the globe on comparative effectiveness research, the highly anticipated CATT (Comparison of AMD Treatment Trials) results, and what impact these and future trials could have on policies, innovation, and patient access. ICER’s Chief Review Officer, Dan Ollendorf, spoke about his definition of CER and his impression of the CATT results.
